Kim SG, Kim KJ, Yoon KH, Chun SW, et al. Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in type 2 diabetes with metabolic syndrome over 24 weeks. Diabetes Obes Metab 2020 May 14. doi: 10.1111/dom.14085.
PMID: 32406573